Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
October 30, 2026
Long-running multidistrict litigation over AbbVie and Teva Pharmaceuticals' agreement to delay generic forms of cholesterol drug Niaspan is headed toward trial, after a Pennsylvania federal judge Friday found a genuine dispute over whether their agreement was a pay-to-delay settlement that violated antitrust laws.
-
October 30, 2026
With former Theranos CEO Elizabeth Holmes' criminal case receiving renewed attention following the recent release of Nathan Fielder and Lance Oppenheim's documentary "You Can See Everything," Law360 answers questions about Holmes' 2022 securities fraud conviction and fact-checks some of the documentary's most talked-about moments.
-
October 30, 2026
A coalition of 23 states and the District of Columbia urged a Rhode Island federal court Friday to let them continue challenging a now-rescinded Trump administration directive to "temporarily" withhold their federal funding, arguing a permanent injunction should still be on the table.
-
October 30, 2026
On Tuesday, voters in Massachusetts and Idaho will consider ballot measures that would roll back or restrict marijuana legalization, marking the first time that all statewide ballot questions on the issue of cannabis are geared toward fighting reform.
-
October 30, 2026
The U.S. Drug Enforcement Administration began registration of more than 900 state-licensed medical marijuana dispensaries across seven states, according to an announcement on Friday by the U.S. Department of Justice, which said applications for manufacturers and distributors would likely require additional review.
See more Life Sciences news